Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Lymphoma). Showing records 1 – 30 of 764 total matches.

[1] [2] [3] [4] [5] … [26]

Search Limiters

Last 2 Years | English Only

Degrees

Levels

Languages

Country

▼ Search Limiters


Rutgers University

1. Garcia, Rolando, 1965-. Unique chromosome aberrations distinguish diffuse large B-cell lynphoma and Burkitt lymphoma: an analysis of cytogenetics and predictor model classifiers.

Degree: PhD, Biomedical Informatics, 2015, Rutgers University

Background: Under current classification of lymphoid neoplasms, majority of lymphomas can be reliably classified; however, overlapping features between diffuse large B-cell lymphoma (DLBCL) and Burkitt… (more)

Subjects/Keywords: B cells; Lymphoma; Burkitt's lymphoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Garcia, Rolando, 1. (2015). Unique chromosome aberrations distinguish diffuse large B-cell lynphoma and Burkitt lymphoma: an analysis of cytogenetics and predictor model classifiers. (Doctoral Dissertation). Rutgers University. Retrieved from https://rucore.libraries.rutgers.edu/rutgers-lib/47330/

Chicago Manual of Style (16th Edition):

Garcia, Rolando, 1965-. “Unique chromosome aberrations distinguish diffuse large B-cell lynphoma and Burkitt lymphoma: an analysis of cytogenetics and predictor model classifiers.” 2015. Doctoral Dissertation, Rutgers University. Accessed September 29, 2020. https://rucore.libraries.rutgers.edu/rutgers-lib/47330/.

MLA Handbook (7th Edition):

Garcia, Rolando, 1965-. “Unique chromosome aberrations distinguish diffuse large B-cell lynphoma and Burkitt lymphoma: an analysis of cytogenetics and predictor model classifiers.” 2015. Web. 29 Sep 2020.

Vancouver:

Garcia, Rolando 1. Unique chromosome aberrations distinguish diffuse large B-cell lynphoma and Burkitt lymphoma: an analysis of cytogenetics and predictor model classifiers. [Internet] [Doctoral dissertation]. Rutgers University; 2015. [cited 2020 Sep 29]. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/47330/.

Council of Science Editors:

Garcia, Rolando 1. Unique chromosome aberrations distinguish diffuse large B-cell lynphoma and Burkitt lymphoma: an analysis of cytogenetics and predictor model classifiers. [Doctoral Dissertation]. Rutgers University; 2015. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/47330/


Addis Ababa University

2. FEREHIWOT, BEKELE. ULTRASOUND PATTERNS OF ABDOMINAL LYMPHOMA AT TIKUR ANBESA HOSPITAL .

Degree: 2014, Addis Ababa University

Lymphoma is a general term for a group of cancers that originate in the lymphatic system and it is the most common hematopoietic malignancy. Overall… (more)

Subjects/Keywords: Lymphoma; hematopoietic

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

FEREHIWOT, B. (2014). ULTRASOUND PATTERNS OF ABDOMINAL LYMPHOMA AT TIKUR ANBESA HOSPITAL . (Thesis). Addis Ababa University. Retrieved from http://etd.aau.edu.et/dspace/handle/123456789/5962

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

FEREHIWOT, BEKELE. “ULTRASOUND PATTERNS OF ABDOMINAL LYMPHOMA AT TIKUR ANBESA HOSPITAL .” 2014. Thesis, Addis Ababa University. Accessed September 29, 2020. http://etd.aau.edu.et/dspace/handle/123456789/5962.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

FEREHIWOT, BEKELE. “ULTRASOUND PATTERNS OF ABDOMINAL LYMPHOMA AT TIKUR ANBESA HOSPITAL .” 2014. Web. 29 Sep 2020.

Vancouver:

FEREHIWOT B. ULTRASOUND PATTERNS OF ABDOMINAL LYMPHOMA AT TIKUR ANBESA HOSPITAL . [Internet] [Thesis]. Addis Ababa University; 2014. [cited 2020 Sep 29]. Available from: http://etd.aau.edu.et/dspace/handle/123456789/5962.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

FEREHIWOT B. ULTRASOUND PATTERNS OF ABDOMINAL LYMPHOMA AT TIKUR ANBESA HOSPITAL . [Thesis]. Addis Ababa University; 2014. Available from: http://etd.aau.edu.et/dspace/handle/123456789/5962

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Illinois – Chicago

3. Carson, Kenneth R. Evaluation of Racial Disparities in United States Veterans with Diffuse Large B-Cell Lymphoma.

Degree: 2015, University of Illinois – Chicago

 There is a well-described, race-based outcome disparity in patients diagnosed with the most common form of non-Hodgkin lymphoma, diffuse large B-cell lymphoma. Despite significant speculation… (more)

Subjects/Keywords: Lymphoma; Disparities; Treatment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Carson, K. R. (2015). Evaluation of Racial Disparities in United States Veterans with Diffuse Large B-Cell Lymphoma. (Thesis). University of Illinois – Chicago. Retrieved from http://hdl.handle.net/10027/19368

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Carson, Kenneth R. “Evaluation of Racial Disparities in United States Veterans with Diffuse Large B-Cell Lymphoma.” 2015. Thesis, University of Illinois – Chicago. Accessed September 29, 2020. http://hdl.handle.net/10027/19368.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Carson, Kenneth R. “Evaluation of Racial Disparities in United States Veterans with Diffuse Large B-Cell Lymphoma.” 2015. Web. 29 Sep 2020.

Vancouver:

Carson KR. Evaluation of Racial Disparities in United States Veterans with Diffuse Large B-Cell Lymphoma. [Internet] [Thesis]. University of Illinois – Chicago; 2015. [cited 2020 Sep 29]. Available from: http://hdl.handle.net/10027/19368.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Carson KR. Evaluation of Racial Disparities in United States Veterans with Diffuse Large B-Cell Lymphoma. [Thesis]. University of Illinois – Chicago; 2015. Available from: http://hdl.handle.net/10027/19368

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Harvard University

4. Lossos, Chen. Harnessing the Tumor Microenvironment for the Treatment of Double Hit Lymphoma.

Degree: PhD, 2019, Harvard University

Since their inception into clinical practice, antibodies have become a mainstay in the treatment of cancer and other diseases. Antibodies eliminate tumor cells through several… (more)

Subjects/Keywords: Alemtuzumab; Chemotherapy; Lymphoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lossos, C. (2019). Harnessing the Tumor Microenvironment for the Treatment of Double Hit Lymphoma. (Doctoral Dissertation). Harvard University. Retrieved from http://nrs.harvard.edu/urn-3:HUL.InstRepos:42029642

Chicago Manual of Style (16th Edition):

Lossos, Chen. “Harnessing the Tumor Microenvironment for the Treatment of Double Hit Lymphoma.” 2019. Doctoral Dissertation, Harvard University. Accessed September 29, 2020. http://nrs.harvard.edu/urn-3:HUL.InstRepos:42029642.

MLA Handbook (7th Edition):

Lossos, Chen. “Harnessing the Tumor Microenvironment for the Treatment of Double Hit Lymphoma.” 2019. Web. 29 Sep 2020.

Vancouver:

Lossos C. Harnessing the Tumor Microenvironment for the Treatment of Double Hit Lymphoma. [Internet] [Doctoral dissertation]. Harvard University; 2019. [cited 2020 Sep 29]. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:42029642.

Council of Science Editors:

Lossos C. Harnessing the Tumor Microenvironment for the Treatment of Double Hit Lymphoma. [Doctoral Dissertation]. Harvard University; 2019. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:42029642


University of Florida

5. Migdady, Yazan. Living in Remission Disparities in Conditional Survival among Non-Hodgkin Lymphoma Survivors.

Degree: MS, Medical Sciences - Clinical Investigation (IDP), 2015, University of Florida

 With advances in therapy, the number of survivors of aggressive and indolent non-Hodgkin lymphoma (NHL) is increasing. Conventional prognostic scores such as the International Prognostic… (more)

Subjects/Keywords: African Americans; B cell lymphoma; B lymphocytes; Burkitt lymphoma; Follicular lymphoma; Income protection insurance; Lymphoma; Non Hodgkin lymphoma; Prognosis; Prophets; burkitts  – follicular  – leukemia  – lymphoma  – non-hodgkin

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Migdady, Y. (2015). Living in Remission Disparities in Conditional Survival among Non-Hodgkin Lymphoma Survivors. (Masters Thesis). University of Florida. Retrieved from https://ufdc.ufl.edu/UFE0047854

Chicago Manual of Style (16th Edition):

Migdady, Yazan. “Living in Remission Disparities in Conditional Survival among Non-Hodgkin Lymphoma Survivors.” 2015. Masters Thesis, University of Florida. Accessed September 29, 2020. https://ufdc.ufl.edu/UFE0047854.

MLA Handbook (7th Edition):

Migdady, Yazan. “Living in Remission Disparities in Conditional Survival among Non-Hodgkin Lymphoma Survivors.” 2015. Web. 29 Sep 2020.

Vancouver:

Migdady Y. Living in Remission Disparities in Conditional Survival among Non-Hodgkin Lymphoma Survivors. [Internet] [Masters thesis]. University of Florida; 2015. [cited 2020 Sep 29]. Available from: https://ufdc.ufl.edu/UFE0047854.

Council of Science Editors:

Migdady Y. Living in Remission Disparities in Conditional Survival among Non-Hodgkin Lymphoma Survivors. [Masters Thesis]. University of Florida; 2015. Available from: https://ufdc.ufl.edu/UFE0047854


University of KwaZulu-Natal

6. Mwazha, Absalom. Gastrointestinal tract plasmablastic lymphoma in HIV infected adults: a histopathological audit.

Degree: 2020, University of KwaZulu-Natal

 Background: Plasmablastic lymphoma (PBL) is an aggressive B-cell lymphoma that is characterised by the expression of plasma cell antigens and loss of pan B-cell antigens.… (more)

Subjects/Keywords: Plasmablastic lymphoma.; HIV-related lymphoma.; AIDS-related lymphoma.; Gastrointestinal tract.; Small intestine.; Colon.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mwazha, A. (2020). Gastrointestinal tract plasmablastic lymphoma in HIV infected adults: a histopathological audit. (Thesis). University of KwaZulu-Natal. Retrieved from https://researchspace.ukzn.ac.za/handle/10413/18599

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Mwazha, Absalom. “Gastrointestinal tract plasmablastic lymphoma in HIV infected adults: a histopathological audit.” 2020. Thesis, University of KwaZulu-Natal. Accessed September 29, 2020. https://researchspace.ukzn.ac.za/handle/10413/18599.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Mwazha, Absalom. “Gastrointestinal tract plasmablastic lymphoma in HIV infected adults: a histopathological audit.” 2020. Web. 29 Sep 2020.

Vancouver:

Mwazha A. Gastrointestinal tract plasmablastic lymphoma in HIV infected adults: a histopathological audit. [Internet] [Thesis]. University of KwaZulu-Natal; 2020. [cited 2020 Sep 29]. Available from: https://researchspace.ukzn.ac.za/handle/10413/18599.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Mwazha A. Gastrointestinal tract plasmablastic lymphoma in HIV infected adults: a histopathological audit. [Thesis]. University of KwaZulu-Natal; 2020. Available from: https://researchspace.ukzn.ac.za/handle/10413/18599

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Sydney

7. Mortlock, Sally-Anne. Genomic diversity and lymphoma predisposition in bullmastiffs .

Degree: 2016, University of Sydney

Lymphoma, cancer of the lymphocytes, is one of the most common malignancies seen in dogs. Studies have reported a high incidence of lymphoma in particular… (more)

Subjects/Keywords: Bullmastiff; Dog; Lymphoma; Genetics; Diversity

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mortlock, S. (2016). Genomic diversity and lymphoma predisposition in bullmastiffs . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/16759

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Mortlock, Sally-Anne. “Genomic diversity and lymphoma predisposition in bullmastiffs .” 2016. Thesis, University of Sydney. Accessed September 29, 2020. http://hdl.handle.net/2123/16759.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Mortlock, Sally-Anne. “Genomic diversity and lymphoma predisposition in bullmastiffs .” 2016. Web. 29 Sep 2020.

Vancouver:

Mortlock S. Genomic diversity and lymphoma predisposition in bullmastiffs . [Internet] [Thesis]. University of Sydney; 2016. [cited 2020 Sep 29]. Available from: http://hdl.handle.net/2123/16759.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Mortlock S. Genomic diversity and lymphoma predisposition in bullmastiffs . [Thesis]. University of Sydney; 2016. Available from: http://hdl.handle.net/2123/16759

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Alberta

8. Pearson, Joel Dylan. Understanding the function of the JunB transcription factor in anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma.

Degree: PhD, Department of Medical Microbiology and Immunology, 2013, University of Alberta

 Anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma (ALK+ ALCL) is a non-Hodgkin lymphoma thought to arise from an activated T lymphocyte. This lymphoma is characterized… (more)

Subjects/Keywords: lymphoma; JunB; ALK+ ALCL

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pearson, J. D. (2013). Understanding the function of the JunB transcription factor in anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma. (Doctoral Dissertation). University of Alberta. Retrieved from https://era.library.ualberta.ca/files/0c483k01k

Chicago Manual of Style (16th Edition):

Pearson, Joel Dylan. “Understanding the function of the JunB transcription factor in anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma.” 2013. Doctoral Dissertation, University of Alberta. Accessed September 29, 2020. https://era.library.ualberta.ca/files/0c483k01k.

MLA Handbook (7th Edition):

Pearson, Joel Dylan. “Understanding the function of the JunB transcription factor in anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma.” 2013. Web. 29 Sep 2020.

Vancouver:

Pearson JD. Understanding the function of the JunB transcription factor in anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma. [Internet] [Doctoral dissertation]. University of Alberta; 2013. [cited 2020 Sep 29]. Available from: https://era.library.ualberta.ca/files/0c483k01k.

Council of Science Editors:

Pearson JD. Understanding the function of the JunB transcription factor in anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma. [Doctoral Dissertation]. University of Alberta; 2013. Available from: https://era.library.ualberta.ca/files/0c483k01k


University of Debrecen

9. Szemes, Katalin. A Hodgkin lymphoma pulmonális megjelenési formái .

Degree: DE – Általános Orvostudományi Kar, University of Debrecen

 Bevezetés: A Hodgkin lymphoma korunk egyik legsikeresebben kezelhető onkohematológiai kórképe. Az extranodalis kiterjedés viszonylag ritka, a tüdő érintettsége a betegek 5,9-11,6%-ánál fordul elő, és általában… (more)

Subjects/Keywords: Hodgkin lymphoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Szemes, K. (n.d.). A Hodgkin lymphoma pulmonális megjelenési formái . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/218534

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Szemes, Katalin. “A Hodgkin lymphoma pulmonális megjelenési formái .” Thesis, University of Debrecen. Accessed September 29, 2020. http://hdl.handle.net/2437/218534.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Szemes, Katalin. “A Hodgkin lymphoma pulmonális megjelenési formái .” Web. 29 Sep 2020.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Szemes K. A Hodgkin lymphoma pulmonális megjelenési formái . [Internet] [Thesis]. University of Debrecen; [cited 2020 Sep 29]. Available from: http://hdl.handle.net/2437/218534.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Szemes K. A Hodgkin lymphoma pulmonális megjelenési formái . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/218534

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


University of Debrecen

10. Sümegi, Mária Flóra. Hodgkin lymphomás betegeink adatainak összefoglaló elemzése .

Degree: DE – Általános Orvostudományi Kar, University of Debrecen

 Bevezetés: A Hodgkin lymphoma (HL) B-sejt eredetű malignus lymphoproliferatív betegség, amely jellemzően fiatal felnőttkorban jelentkezik, és nyirokcsomó megnagyobbodással, esetleg lép- és májduzzanattal, valamint általános tünetekkel… (more)

Subjects/Keywords: Hodgkin-lymphoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sümegi, M. F. (n.d.). Hodgkin lymphomás betegeink adatainak összefoglaló elemzése . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/201481

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sümegi, Mária Flóra. “Hodgkin lymphomás betegeink adatainak összefoglaló elemzése .” Thesis, University of Debrecen. Accessed September 29, 2020. http://hdl.handle.net/2437/201481.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sümegi, Mária Flóra. “Hodgkin lymphomás betegeink adatainak összefoglaló elemzése .” Web. 29 Sep 2020.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Sümegi MF. Hodgkin lymphomás betegeink adatainak összefoglaló elemzése . [Internet] [Thesis]. University of Debrecen; [cited 2020 Sep 29]. Available from: http://hdl.handle.net/2437/201481.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Sümegi MF. Hodgkin lymphomás betegeink adatainak összefoglaló elemzése . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/201481

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


Boston University

11. Detrick, Jordan. Rheumatoid arthritis and lymphoma: the role of disease-modifying anti-rheumatic drugs.

Degree: MS, Medical Sciences, 2018, Boston University

 A well-functioning immune system is of paramount importance in preventing lymphomagenesis. Both immunostimulation, which causes excessive cell turnover and increased potential for mutations, and immunosuppression,… (more)

Subjects/Keywords: Medicine; DMARD; Lymphoma; Rheumatoid arthritis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Detrick, J. (2018). Rheumatoid arthritis and lymphoma: the role of disease-modifying anti-rheumatic drugs. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/31156

Chicago Manual of Style (16th Edition):

Detrick, Jordan. “Rheumatoid arthritis and lymphoma: the role of disease-modifying anti-rheumatic drugs.” 2018. Masters Thesis, Boston University. Accessed September 29, 2020. http://hdl.handle.net/2144/31156.

MLA Handbook (7th Edition):

Detrick, Jordan. “Rheumatoid arthritis and lymphoma: the role of disease-modifying anti-rheumatic drugs.” 2018. Web. 29 Sep 2020.

Vancouver:

Detrick J. Rheumatoid arthritis and lymphoma: the role of disease-modifying anti-rheumatic drugs. [Internet] [Masters thesis]. Boston University; 2018. [cited 2020 Sep 29]. Available from: http://hdl.handle.net/2144/31156.

Council of Science Editors:

Detrick J. Rheumatoid arthritis and lymphoma: the role of disease-modifying anti-rheumatic drugs. [Masters Thesis]. Boston University; 2018. Available from: http://hdl.handle.net/2144/31156


Univerzitet u Beogradu

12. Jaković, Ljubomir R., 1975-. Korelacija kliničkih parametara i bioloških markera apoptoze u prognozi klasičnog Hočkinovog limfoma.

Degree: Medicinski fakultet, 2014, Univerzitet u Beogradu

Medicina - Hematologija / Medicine - Hematology

Hočkinov limfom (HL) je izlečiv tumor, međutim savremeni pristupi lečenju ove bolesti nisu precizni. Prognozna vrednost bioloških i… (more)

Subjects/Keywords: Prognostic parameters; advanced Hodgkin’s lymphoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jaković, Ljubomir R., 1. (2014). Korelacija kliničkih parametara i bioloških markera apoptoze u prognozi klasičnog Hočkinovog limfoma. (Thesis). Univerzitet u Beogradu. Retrieved from https://fedorabg.bg.ac.rs/fedora/get/o:6863/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Jaković, Ljubomir R., 1975-. “Korelacija kliničkih parametara i bioloških markera apoptoze u prognozi klasičnog Hočkinovog limfoma.” 2014. Thesis, Univerzitet u Beogradu. Accessed September 29, 2020. https://fedorabg.bg.ac.rs/fedora/get/o:6863/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Jaković, Ljubomir R., 1975-. “Korelacija kliničkih parametara i bioloških markera apoptoze u prognozi klasičnog Hočkinovog limfoma.” 2014. Web. 29 Sep 2020.

Vancouver:

Jaković, Ljubomir R. 1. Korelacija kliničkih parametara i bioloških markera apoptoze u prognozi klasičnog Hočkinovog limfoma. [Internet] [Thesis]. Univerzitet u Beogradu; 2014. [cited 2020 Sep 29]. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:6863/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Jaković, Ljubomir R. 1. Korelacija kliničkih parametara i bioloških markera apoptoze u prognozi klasičnog Hočkinovog limfoma. [Thesis]. Univerzitet u Beogradu; 2014. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:6863/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Manitoba

13. Skrabek, Pamela. Examining the pathway to diagnosis and treatment of lymphoma in Manitoba: patient and system factors resulting in delay.

Degree: Community Health Sciences, 2016, University of Manitoba

 The province of Manitoba has set a goal of reducing time from suspicion of cancer to treatment to a target of sixty days. To attain… (more)

Subjects/Keywords: Lymphoma; delay; clinical pathway

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Skrabek, P. (2016). Examining the pathway to diagnosis and treatment of lymphoma in Manitoba: patient and system factors resulting in delay. (Masters Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/31987

Chicago Manual of Style (16th Edition):

Skrabek, Pamela. “Examining the pathway to diagnosis and treatment of lymphoma in Manitoba: patient and system factors resulting in delay.” 2016. Masters Thesis, University of Manitoba. Accessed September 29, 2020. http://hdl.handle.net/1993/31987.

MLA Handbook (7th Edition):

Skrabek, Pamela. “Examining the pathway to diagnosis and treatment of lymphoma in Manitoba: patient and system factors resulting in delay.” 2016. Web. 29 Sep 2020.

Vancouver:

Skrabek P. Examining the pathway to diagnosis and treatment of lymphoma in Manitoba: patient and system factors resulting in delay. [Internet] [Masters thesis]. University of Manitoba; 2016. [cited 2020 Sep 29]. Available from: http://hdl.handle.net/1993/31987.

Council of Science Editors:

Skrabek P. Examining the pathway to diagnosis and treatment of lymphoma in Manitoba: patient and system factors resulting in delay. [Masters Thesis]. University of Manitoba; 2016. Available from: http://hdl.handle.net/1993/31987


University of Oxford

14. Sheikh, Semira. Translational development of MyD88 as a biomarker for selecting patients with lymphoma responsive to histone deacetylase inhibitors.

Degree: PhD, 2017, University of Oxford

 Histone deacetylase inhibitors (HDIs) are promising new agents for the treatment of haematological malignancy including lymphoma. MyD88 expression and secretion of pro-inflammatory cytokines may contribute… (more)

Subjects/Keywords: lymphoma biology; cancer biomarkers

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sheikh, S. (2017). Translational development of MyD88 as a biomarker for selecting patients with lymphoma responsive to histone deacetylase inhibitors. (Doctoral Dissertation). University of Oxford. Retrieved from http://ora.ox.ac.uk/objects/uuid:a6663eee-d708-4e1a-95d6-c142d04011d6 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.770361

Chicago Manual of Style (16th Edition):

Sheikh, Semira. “Translational development of MyD88 as a biomarker for selecting patients with lymphoma responsive to histone deacetylase inhibitors.” 2017. Doctoral Dissertation, University of Oxford. Accessed September 29, 2020. http://ora.ox.ac.uk/objects/uuid:a6663eee-d708-4e1a-95d6-c142d04011d6 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.770361.

MLA Handbook (7th Edition):

Sheikh, Semira. “Translational development of MyD88 as a biomarker for selecting patients with lymphoma responsive to histone deacetylase inhibitors.” 2017. Web. 29 Sep 2020.

Vancouver:

Sheikh S. Translational development of MyD88 as a biomarker for selecting patients with lymphoma responsive to histone deacetylase inhibitors. [Internet] [Doctoral dissertation]. University of Oxford; 2017. [cited 2020 Sep 29]. Available from: http://ora.ox.ac.uk/objects/uuid:a6663eee-d708-4e1a-95d6-c142d04011d6 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.770361.

Council of Science Editors:

Sheikh S. Translational development of MyD88 as a biomarker for selecting patients with lymphoma responsive to histone deacetylase inhibitors. [Doctoral Dissertation]. University of Oxford; 2017. Available from: http://ora.ox.ac.uk/objects/uuid:a6663eee-d708-4e1a-95d6-c142d04011d6 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.770361


Queen Mary, University of London

15. McCarthy, Áine Claire. Study of the roles of autophagy in human follicular and diffuse large B-cell lymphoma.

Degree: PhD, 2014, Queen Mary, University of London

 Autophagy, a cellular self-degradation process, plays important roles in cancer development and progression. Autophagy can be inhibited by the anti-apoptotic protein BCL-2 which binds and… (more)

Subjects/Keywords: 616.99; Cancer; Lymphoma; Autophagy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

McCarthy, . C. (2014). Study of the roles of autophagy in human follicular and diffuse large B-cell lymphoma. (Doctoral Dissertation). Queen Mary, University of London. Retrieved from http://qmro.qmul.ac.uk/xmlui/handle/123456789/8760 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.667272

Chicago Manual of Style (16th Edition):

McCarthy, Áine Claire. “Study of the roles of autophagy in human follicular and diffuse large B-cell lymphoma.” 2014. Doctoral Dissertation, Queen Mary, University of London. Accessed September 29, 2020. http://qmro.qmul.ac.uk/xmlui/handle/123456789/8760 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.667272.

MLA Handbook (7th Edition):

McCarthy, Áine Claire. “Study of the roles of autophagy in human follicular and diffuse large B-cell lymphoma.” 2014. Web. 29 Sep 2020.

Vancouver:

McCarthy C. Study of the roles of autophagy in human follicular and diffuse large B-cell lymphoma. [Internet] [Doctoral dissertation]. Queen Mary, University of London; 2014. [cited 2020 Sep 29]. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/8760 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.667272.

Council of Science Editors:

McCarthy C. Study of the roles of autophagy in human follicular and diffuse large B-cell lymphoma. [Doctoral Dissertation]. Queen Mary, University of London; 2014. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/8760 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.667272


University of Edinburgh

16. Doig, Tamasin Naomi. Tumour associated macrophages in Diffuse Large B cell lymphoma.

Degree: PhD, 2016, University of Edinburgh

 Tumour associated macrophages (TAMs) have been associated with prognosis in a wide variety of tumours with most studies showing a high number of macrophages equating… (more)

Subjects/Keywords: 616.99; lymphoma; macrophages; tumour microenvironment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Doig, T. N. (2016). Tumour associated macrophages in Diffuse Large B cell lymphoma. (Doctoral Dissertation). University of Edinburgh. Retrieved from http://hdl.handle.net/1842/25475

Chicago Manual of Style (16th Edition):

Doig, Tamasin Naomi. “Tumour associated macrophages in Diffuse Large B cell lymphoma.” 2016. Doctoral Dissertation, University of Edinburgh. Accessed September 29, 2020. http://hdl.handle.net/1842/25475.

MLA Handbook (7th Edition):

Doig, Tamasin Naomi. “Tumour associated macrophages in Diffuse Large B cell lymphoma.” 2016. Web. 29 Sep 2020.

Vancouver:

Doig TN. Tumour associated macrophages in Diffuse Large B cell lymphoma. [Internet] [Doctoral dissertation]. University of Edinburgh; 2016. [cited 2020 Sep 29]. Available from: http://hdl.handle.net/1842/25475.

Council of Science Editors:

Doig TN. Tumour associated macrophages in Diffuse Large B cell lymphoma. [Doctoral Dissertation]. University of Edinburgh; 2016. Available from: http://hdl.handle.net/1842/25475


University of Sydney

17. Al Mazi, Juhura Gania. P53 responses to fludarabine in human B-lymphoid cancers .

Degree: 2013, University of Sydney

 The tumour suppressor protein p53, is a transcription factor responsible for regulating the cell cycle and/or apoptosis in proliferating cells subjected to a variety of… (more)

Subjects/Keywords: Fludarabine; B-lymphoma; P53; Phosphorylation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Al Mazi, J. G. (2013). P53 responses to fludarabine in human B-lymphoid cancers . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/10401

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Al Mazi, Juhura Gania. “P53 responses to fludarabine in human B-lymphoid cancers .” 2013. Thesis, University of Sydney. Accessed September 29, 2020. http://hdl.handle.net/2123/10401.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Al Mazi, Juhura Gania. “P53 responses to fludarabine in human B-lymphoid cancers .” 2013. Web. 29 Sep 2020.

Vancouver:

Al Mazi JG. P53 responses to fludarabine in human B-lymphoid cancers . [Internet] [Thesis]. University of Sydney; 2013. [cited 2020 Sep 29]. Available from: http://hdl.handle.net/2123/10401.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Al Mazi JG. P53 responses to fludarabine in human B-lymphoid cancers . [Thesis]. University of Sydney; 2013. Available from: http://hdl.handle.net/2123/10401

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universidad de Cantabria

18. García Díaz, Nuria. Novel approaches for targeted therapy in CTCL.

Degree: Máster en Biología Molecular y Biomedicina, 2013, Universidad de Cantabria

 Development of targeted therapy for Cutaneous T-Cell Lymphoma (CTCL) patients still requires actionable mutated genes and deregulated pathways to be identified. Although it has been… (more)

Subjects/Keywords: Cutaneous T-Cell Lymphoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

García Díaz, N. (2013). Novel approaches for targeted therapy in CTCL. (Masters Thesis). Universidad de Cantabria. Retrieved from http://hdl.handle.net/10902/4194

Chicago Manual of Style (16th Edition):

García Díaz, Nuria. “Novel approaches for targeted therapy in CTCL.” 2013. Masters Thesis, Universidad de Cantabria. Accessed September 29, 2020. http://hdl.handle.net/10902/4194.

MLA Handbook (7th Edition):

García Díaz, Nuria. “Novel approaches for targeted therapy in CTCL.” 2013. Web. 29 Sep 2020.

Vancouver:

García Díaz N. Novel approaches for targeted therapy in CTCL. [Internet] [Masters thesis]. Universidad de Cantabria; 2013. [cited 2020 Sep 29]. Available from: http://hdl.handle.net/10902/4194.

Council of Science Editors:

García Díaz N. Novel approaches for targeted therapy in CTCL. [Masters Thesis]. Universidad de Cantabria; 2013. Available from: http://hdl.handle.net/10902/4194


University of Melbourne

19. GRABOW, STEPHANIE. Which pro-survival Bcl-2 family members are required for lymphoma development and sustained lymphoma growth.

Degree: 2011, University of Melbourne

 Apoptosis is a form of programmed cell death that is critical for embryonic development, tissue homeostasis and regulation of the immune system of multi-cellular organisms.… (more)

Subjects/Keywords: Bcl-2 family; apoptosis; lymphoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

GRABOW, S. (2011). Which pro-survival Bcl-2 family members are required for lymphoma development and sustained lymphoma growth. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/37023

Chicago Manual of Style (16th Edition):

GRABOW, STEPHANIE. “Which pro-survival Bcl-2 family members are required for lymphoma development and sustained lymphoma growth.” 2011. Doctoral Dissertation, University of Melbourne. Accessed September 29, 2020. http://hdl.handle.net/11343/37023.

MLA Handbook (7th Edition):

GRABOW, STEPHANIE. “Which pro-survival Bcl-2 family members are required for lymphoma development and sustained lymphoma growth.” 2011. Web. 29 Sep 2020.

Vancouver:

GRABOW S. Which pro-survival Bcl-2 family members are required for lymphoma development and sustained lymphoma growth. [Internet] [Doctoral dissertation]. University of Melbourne; 2011. [cited 2020 Sep 29]. Available from: http://hdl.handle.net/11343/37023.

Council of Science Editors:

GRABOW S. Which pro-survival Bcl-2 family members are required for lymphoma development and sustained lymphoma growth. [Doctoral Dissertation]. University of Melbourne; 2011. Available from: http://hdl.handle.net/11343/37023


University of Melbourne

20. Gates, Priscilla Ruth. A pilot study to test a novel, nurse-led intervention to enhance the general health status of survivors of Hodgkin lymphoma attending a multidisciplinary, haematology late effects clinic.

Degree: 2013, University of Melbourne

 Background: The increasing numbers of Hodgkin Lymphoma (HL) survivors has raised awareness of the need to optimise long-term health outcomes and quality of life for… (more)

Subjects/Keywords: Hodgkin lymphoma; survivorship; nurse-led

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gates, P. R. (2013). A pilot study to test a novel, nurse-led intervention to enhance the general health status of survivors of Hodgkin lymphoma attending a multidisciplinary, haematology late effects clinic. (Masters Thesis). University of Melbourne. Retrieved from http://hdl.handle.net/11343/38365

Chicago Manual of Style (16th Edition):

Gates, Priscilla Ruth. “A pilot study to test a novel, nurse-led intervention to enhance the general health status of survivors of Hodgkin lymphoma attending a multidisciplinary, haematology late effects clinic.” 2013. Masters Thesis, University of Melbourne. Accessed September 29, 2020. http://hdl.handle.net/11343/38365.

MLA Handbook (7th Edition):

Gates, Priscilla Ruth. “A pilot study to test a novel, nurse-led intervention to enhance the general health status of survivors of Hodgkin lymphoma attending a multidisciplinary, haematology late effects clinic.” 2013. Web. 29 Sep 2020.

Vancouver:

Gates PR. A pilot study to test a novel, nurse-led intervention to enhance the general health status of survivors of Hodgkin lymphoma attending a multidisciplinary, haematology late effects clinic. [Internet] [Masters thesis]. University of Melbourne; 2013. [cited 2020 Sep 29]. Available from: http://hdl.handle.net/11343/38365.

Council of Science Editors:

Gates PR. A pilot study to test a novel, nurse-led intervention to enhance the general health status of survivors of Hodgkin lymphoma attending a multidisciplinary, haematology late effects clinic. [Masters Thesis]. University of Melbourne; 2013. Available from: http://hdl.handle.net/11343/38365


University of Melbourne

21. Gregory, Gareth Peter. Targeting cyclin-dependent kinase 9 and myeloid cell leukaemia 1 in MYC-driven B-cell lymphoma.

Degree: 2016, University of Melbourne

 Aggressive B-cell lymphomas include diffuse large B-cell lymphoma, Burkitt lymphoma and intermediate forms. Despite high response rates to conventional immuno-chemotherapeutic approaches, an unmet need for… (more)

Subjects/Keywords: lymphoma; MYC; CDK9; MCL1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gregory, G. P. (2016). Targeting cyclin-dependent kinase 9 and myeloid cell leukaemia 1 in MYC-driven B-cell lymphoma. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/123954

Chicago Manual of Style (16th Edition):

Gregory, Gareth Peter. “Targeting cyclin-dependent kinase 9 and myeloid cell leukaemia 1 in MYC-driven B-cell lymphoma.” 2016. Doctoral Dissertation, University of Melbourne. Accessed September 29, 2020. http://hdl.handle.net/11343/123954.

MLA Handbook (7th Edition):

Gregory, Gareth Peter. “Targeting cyclin-dependent kinase 9 and myeloid cell leukaemia 1 in MYC-driven B-cell lymphoma.” 2016. Web. 29 Sep 2020.

Vancouver:

Gregory GP. Targeting cyclin-dependent kinase 9 and myeloid cell leukaemia 1 in MYC-driven B-cell lymphoma. [Internet] [Doctoral dissertation]. University of Melbourne; 2016. [cited 2020 Sep 29]. Available from: http://hdl.handle.net/11343/123954.

Council of Science Editors:

Gregory GP. Targeting cyclin-dependent kinase 9 and myeloid cell leukaemia 1 in MYC-driven B-cell lymphoma. [Doctoral Dissertation]. University of Melbourne; 2016. Available from: http://hdl.handle.net/11343/123954


University of Guelph

22. Craig, Karlee. MicroRNA profiling in canine multicentric lymphoma.

Degree: Doctor of Veterinary Science, Department of Pathobiology, 2019, University of Guelph

Lymphoma is the most common hematopoietic tumour in dogs and has significant overlap with the human disease. Tumour biomarker discovery is providing new tools for… (more)

Subjects/Keywords: microRNA; miRNA; canine; lymphoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Craig, K. (2019). MicroRNA profiling in canine multicentric lymphoma. (Doctoral Dissertation). University of Guelph. Retrieved from https://atrium.lib.uoguelph.ca/xmlui/handle/10214/15863

Chicago Manual of Style (16th Edition):

Craig, Karlee. “MicroRNA profiling in canine multicentric lymphoma.” 2019. Doctoral Dissertation, University of Guelph. Accessed September 29, 2020. https://atrium.lib.uoguelph.ca/xmlui/handle/10214/15863.

MLA Handbook (7th Edition):

Craig, Karlee. “MicroRNA profiling in canine multicentric lymphoma.” 2019. Web. 29 Sep 2020.

Vancouver:

Craig K. MicroRNA profiling in canine multicentric lymphoma. [Internet] [Doctoral dissertation]. University of Guelph; 2019. [cited 2020 Sep 29]. Available from: https://atrium.lib.uoguelph.ca/xmlui/handle/10214/15863.

Council of Science Editors:

Craig K. MicroRNA profiling in canine multicentric lymphoma. [Doctoral Dissertation]. University of Guelph; 2019. Available from: https://atrium.lib.uoguelph.ca/xmlui/handle/10214/15863


Victoria University of Wellington

23. George, Philip. A Phase 1 Dose Escalation Trial of Third Generation Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed and Refractory B-Cell Non Hodgkin Lymphoma.

Degree: 2020, Victoria University of Wellington

 Anti-CD19 Chimeric Antigen Receptor (CAR) T-cell therapy is shifting the treatment paradigm internationally for selected patients with relapsed and refractory B-cell Non- Hodgkin Lymphoma. Despite… (more)

Subjects/Keywords: Lymphoma; Chimeric Antigen Receptor; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

George, P. (2020). A Phase 1 Dose Escalation Trial of Third Generation Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed and Refractory B-Cell Non Hodgkin Lymphoma. (Masters Thesis). Victoria University of Wellington. Retrieved from http://hdl.handle.net/10063/9103

Chicago Manual of Style (16th Edition):

George, Philip. “A Phase 1 Dose Escalation Trial of Third Generation Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed and Refractory B-Cell Non Hodgkin Lymphoma.” 2020. Masters Thesis, Victoria University of Wellington. Accessed September 29, 2020. http://hdl.handle.net/10063/9103.

MLA Handbook (7th Edition):

George, Philip. “A Phase 1 Dose Escalation Trial of Third Generation Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed and Refractory B-Cell Non Hodgkin Lymphoma.” 2020. Web. 29 Sep 2020.

Vancouver:

George P. A Phase 1 Dose Escalation Trial of Third Generation Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed and Refractory B-Cell Non Hodgkin Lymphoma. [Internet] [Masters thesis]. Victoria University of Wellington; 2020. [cited 2020 Sep 29]. Available from: http://hdl.handle.net/10063/9103.

Council of Science Editors:

George P. A Phase 1 Dose Escalation Trial of Third Generation Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed and Refractory B-Cell Non Hodgkin Lymphoma. [Masters Thesis]. Victoria University of Wellington; 2020. Available from: http://hdl.handle.net/10063/9103


University of Plymouth

24. Thompson, Hannah Patricia. Exploring the sensitivity of mantle cell lymphoma to inhibitors of Bruton's tyrosine kinase.

Degree: PhD, 2019, University of Plymouth

 Mantle cell lymphoma (MCL) is an incurable B-cell lymphoma which responds poorly to conventional chemotherapy. Inhibitors of Bruton's tyrosine kinase (BTKi) have shown a significant… (more)

Subjects/Keywords: BTK inhibitors; Mantle cell lymphoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Thompson, H. P. (2019). Exploring the sensitivity of mantle cell lymphoma to inhibitors of Bruton's tyrosine kinase. (Doctoral Dissertation). University of Plymouth. Retrieved from http://hdl.handle.net/10026.1/14694

Chicago Manual of Style (16th Edition):

Thompson, Hannah Patricia. “Exploring the sensitivity of mantle cell lymphoma to inhibitors of Bruton's tyrosine kinase.” 2019. Doctoral Dissertation, University of Plymouth. Accessed September 29, 2020. http://hdl.handle.net/10026.1/14694.

MLA Handbook (7th Edition):

Thompson, Hannah Patricia. “Exploring the sensitivity of mantle cell lymphoma to inhibitors of Bruton's tyrosine kinase.” 2019. Web. 29 Sep 2020.

Vancouver:

Thompson HP. Exploring the sensitivity of mantle cell lymphoma to inhibitors of Bruton's tyrosine kinase. [Internet] [Doctoral dissertation]. University of Plymouth; 2019. [cited 2020 Sep 29]. Available from: http://hdl.handle.net/10026.1/14694.

Council of Science Editors:

Thompson HP. Exploring the sensitivity of mantle cell lymphoma to inhibitors of Bruton's tyrosine kinase. [Doctoral Dissertation]. University of Plymouth; 2019. Available from: http://hdl.handle.net/10026.1/14694


University of the Western Cape

25. Elamin, Hassan Elzain. Incidence of plasmablastic lymphoma in HIV positive and negative patients at a tertiary hospital in South Africa (2005-2017) .

Degree: 2018, University of the Western Cape

 The aim of the study was to investigate and describe the incidence of Plasmablastic Lymphoma (PBL) diagnosed at the Divisions of Anatomical Pathology and Haematopathology… (more)

Subjects/Keywords: Plasmablastic lymphoma; HIV; Tygerberg Hospital; Plasmablastic Lymphoma; HIV

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Elamin, H. E. (2018). Incidence of plasmablastic lymphoma in HIV positive and negative patients at a tertiary hospital in South Africa (2005-2017) . (Thesis). University of the Western Cape. Retrieved from http://hdl.handle.net/11394/6627

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Elamin, Hassan Elzain. “Incidence of plasmablastic lymphoma in HIV positive and negative patients at a tertiary hospital in South Africa (2005-2017) .” 2018. Thesis, University of the Western Cape. Accessed September 29, 2020. http://hdl.handle.net/11394/6627.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Elamin, Hassan Elzain. “Incidence of plasmablastic lymphoma in HIV positive and negative patients at a tertiary hospital in South Africa (2005-2017) .” 2018. Web. 29 Sep 2020.

Vancouver:

Elamin HE. Incidence of plasmablastic lymphoma in HIV positive and negative patients at a tertiary hospital in South Africa (2005-2017) . [Internet] [Thesis]. University of the Western Cape; 2018. [cited 2020 Sep 29]. Available from: http://hdl.handle.net/11394/6627.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Elamin HE. Incidence of plasmablastic lymphoma in HIV positive and negative patients at a tertiary hospital in South Africa (2005-2017) . [Thesis]. University of the Western Cape; 2018. Available from: http://hdl.handle.net/11394/6627

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Université Paris-Sud – Paris XI

26. Bousseton, Munier. Neuroblastome, résistance in vivo à l'irinotecan et voie de signalisation ALK : Neuroblastoma, in vivo resistance to irinotecan and ALK signaling pathway.

Degree: Docteur es, Pharmacologie, Biologie cellulaire et moléculaire, 2012, Université Paris-Sud – Paris XI

Les neuroblastomes, même de haut risque répondent bien à la chimiothérapie initiale mais deviendront fréquemment résistants au traitement. Les inhibiteurs de topoisomérase I représentent un… (more)

Subjects/Keywords: Neuroblastome; Résistance; Anaplastique Lymphoma Kinase; Neuroblastoma; Resistance; Anaplastic Lymphoma Kinase

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bousseton, M. (2012). Neuroblastome, résistance in vivo à l'irinotecan et voie de signalisation ALK : Neuroblastoma, in vivo resistance to irinotecan and ALK signaling pathway. (Doctoral Dissertation). Université Paris-Sud – Paris XI. Retrieved from http://www.theses.fr/2012PA11T025

Chicago Manual of Style (16th Edition):

Bousseton, Munier. “Neuroblastome, résistance in vivo à l'irinotecan et voie de signalisation ALK : Neuroblastoma, in vivo resistance to irinotecan and ALK signaling pathway.” 2012. Doctoral Dissertation, Université Paris-Sud – Paris XI. Accessed September 29, 2020. http://www.theses.fr/2012PA11T025.

MLA Handbook (7th Edition):

Bousseton, Munier. “Neuroblastome, résistance in vivo à l'irinotecan et voie de signalisation ALK : Neuroblastoma, in vivo resistance to irinotecan and ALK signaling pathway.” 2012. Web. 29 Sep 2020.

Vancouver:

Bousseton M. Neuroblastome, résistance in vivo à l'irinotecan et voie de signalisation ALK : Neuroblastoma, in vivo resistance to irinotecan and ALK signaling pathway. [Internet] [Doctoral dissertation]. Université Paris-Sud – Paris XI; 2012. [cited 2020 Sep 29]. Available from: http://www.theses.fr/2012PA11T025.

Council of Science Editors:

Bousseton M. Neuroblastome, résistance in vivo à l'irinotecan et voie de signalisation ALK : Neuroblastoma, in vivo resistance to irinotecan and ALK signaling pathway. [Doctoral Dissertation]. Université Paris-Sud – Paris XI; 2012. Available from: http://www.theses.fr/2012PA11T025


University of Guelph

27. Gow, William R. Micro-RNA Profiling for the Diagnosis and Prognosis of Canine Multicentric Lymphoma.

Degree: Doctor of Veterinary Science, Department of Pathobiology, 2015, University of Guelph

 MicroRNAs (miRs) are small non-coding RNAs (18-22 nucleotides in length) that have important roles in mRNA translation and hence expression of proteins. Dysregulated miR expression… (more)

Subjects/Keywords: biomarker; microRNA; micro-RNA; lymphoma; canine lymphoma; chemotherapy; plasma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gow, W. R. (2015). Micro-RNA Profiling for the Diagnosis and Prognosis of Canine Multicentric Lymphoma. (Doctoral Dissertation). University of Guelph. Retrieved from https://atrium.lib.uoguelph.ca/xmlui/handle/10214/8886

Chicago Manual of Style (16th Edition):

Gow, William R. “Micro-RNA Profiling for the Diagnosis and Prognosis of Canine Multicentric Lymphoma.” 2015. Doctoral Dissertation, University of Guelph. Accessed September 29, 2020. https://atrium.lib.uoguelph.ca/xmlui/handle/10214/8886.

MLA Handbook (7th Edition):

Gow, William R. “Micro-RNA Profiling for the Diagnosis and Prognosis of Canine Multicentric Lymphoma.” 2015. Web. 29 Sep 2020.

Vancouver:

Gow WR. Micro-RNA Profiling for the Diagnosis and Prognosis of Canine Multicentric Lymphoma. [Internet] [Doctoral dissertation]. University of Guelph; 2015. [cited 2020 Sep 29]. Available from: https://atrium.lib.uoguelph.ca/xmlui/handle/10214/8886.

Council of Science Editors:

Gow WR. Micro-RNA Profiling for the Diagnosis and Prognosis of Canine Multicentric Lymphoma. [Doctoral Dissertation]. University of Guelph; 2015. Available from: https://atrium.lib.uoguelph.ca/xmlui/handle/10214/8886


Boston University

28. Butsenko, Dmitriy. Effectiveness of novel immunotherapy and chemotherapy treatments for follicular and diffuse large B-cell lymphomas.

Degree: MS, Medical Sciences, 2017, Boston University

 The efficacy of therapeutic modalities for non-Hodgkin’s lymphoma have been tested and improved throughout the 19th century through various series of drug trials aimed at… (more)

Subjects/Keywords: Medicine; Diffuse large B-cell lymphoma; Follicular lymhpoma; Non-Hodgkin lymphoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Butsenko, D. (2017). Effectiveness of novel immunotherapy and chemotherapy treatments for follicular and diffuse large B-cell lymphomas. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/23746

Chicago Manual of Style (16th Edition):

Butsenko, Dmitriy. “Effectiveness of novel immunotherapy and chemotherapy treatments for follicular and diffuse large B-cell lymphomas.” 2017. Masters Thesis, Boston University. Accessed September 29, 2020. http://hdl.handle.net/2144/23746.

MLA Handbook (7th Edition):

Butsenko, Dmitriy. “Effectiveness of novel immunotherapy and chemotherapy treatments for follicular and diffuse large B-cell lymphomas.” 2017. Web. 29 Sep 2020.

Vancouver:

Butsenko D. Effectiveness of novel immunotherapy and chemotherapy treatments for follicular and diffuse large B-cell lymphomas. [Internet] [Masters thesis]. Boston University; 2017. [cited 2020 Sep 29]. Available from: http://hdl.handle.net/2144/23746.

Council of Science Editors:

Butsenko D. Effectiveness of novel immunotherapy and chemotherapy treatments for follicular and diffuse large B-cell lymphomas. [Masters Thesis]. Boston University; 2017. Available from: http://hdl.handle.net/2144/23746


University of Oxford

29. Wong, Kah-Keng. Validation of lymphoma-associated antigens identified using autoantibody profiling and protein arrays.

Degree: PhD, 2011, University of Oxford

 Diffuse large B-cell lymphoma (DLBCL) is an aggressive lymphoma subtype with heterogeneous clinical outcome and a significant number of patients still die of their disease.… (more)

Subjects/Keywords: 616.15; Molecular haematology; Lymphoma antigens; Tumour pathology; Lymphoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wong, K. (2011). Validation of lymphoma-associated antigens identified using autoantibody profiling and protein arrays. (Doctoral Dissertation). University of Oxford. Retrieved from http://ora.ox.ac.uk/objects/uuid:51ac6bbe-2845-43cc-9b7a-cb92097155f1 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.534013

Chicago Manual of Style (16th Edition):

Wong, Kah-Keng. “Validation of lymphoma-associated antigens identified using autoantibody profiling and protein arrays.” 2011. Doctoral Dissertation, University of Oxford. Accessed September 29, 2020. http://ora.ox.ac.uk/objects/uuid:51ac6bbe-2845-43cc-9b7a-cb92097155f1 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.534013.

MLA Handbook (7th Edition):

Wong, Kah-Keng. “Validation of lymphoma-associated antigens identified using autoantibody profiling and protein arrays.” 2011. Web. 29 Sep 2020.

Vancouver:

Wong K. Validation of lymphoma-associated antigens identified using autoantibody profiling and protein arrays. [Internet] [Doctoral dissertation]. University of Oxford; 2011. [cited 2020 Sep 29]. Available from: http://ora.ox.ac.uk/objects/uuid:51ac6bbe-2845-43cc-9b7a-cb92097155f1 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.534013.

Council of Science Editors:

Wong K. Validation of lymphoma-associated antigens identified using autoantibody profiling and protein arrays. [Doctoral Dissertation]. University of Oxford; 2011. Available from: http://ora.ox.ac.uk/objects/uuid:51ac6bbe-2845-43cc-9b7a-cb92097155f1 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.534013


Queen Mary, University of London

30. Iyengar, Sunil. Investigating the role of Class Ia phosphoinositide-3 kinase isoforms in Mantle Cell Lymphoma.

Degree: PhD, 2013, Queen Mary, University of London

 Mantle Cell Lymphoma (MCL) is a rare but aggressive Non-Hodgkin Lymphoma (NHL). Although t(11;14) is a hallmark of MCL, it is insufficient for lymphomagenesis. The… (more)

Subjects/Keywords: 616.99; Medicine; Haemato-Oncology; Mantle Cell Lymphoma; Non-Hodgkin's Lymphoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Iyengar, S. (2013). Investigating the role of Class Ia phosphoinositide-3 kinase isoforms in Mantle Cell Lymphoma. (Doctoral Dissertation). Queen Mary, University of London. Retrieved from http://qmro.qmul.ac.uk/xmlui/handle/123456789/8689 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.667172

Chicago Manual of Style (16th Edition):

Iyengar, Sunil. “Investigating the role of Class Ia phosphoinositide-3 kinase isoforms in Mantle Cell Lymphoma.” 2013. Doctoral Dissertation, Queen Mary, University of London. Accessed September 29, 2020. http://qmro.qmul.ac.uk/xmlui/handle/123456789/8689 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.667172.

MLA Handbook (7th Edition):

Iyengar, Sunil. “Investigating the role of Class Ia phosphoinositide-3 kinase isoforms in Mantle Cell Lymphoma.” 2013. Web. 29 Sep 2020.

Vancouver:

Iyengar S. Investigating the role of Class Ia phosphoinositide-3 kinase isoforms in Mantle Cell Lymphoma. [Internet] [Doctoral dissertation]. Queen Mary, University of London; 2013. [cited 2020 Sep 29]. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/8689 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.667172.

Council of Science Editors:

Iyengar S. Investigating the role of Class Ia phosphoinositide-3 kinase isoforms in Mantle Cell Lymphoma. [Doctoral Dissertation]. Queen Mary, University of London; 2013. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/8689 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.667172

[1] [2] [3] [4] [5] … [26]

.